Gut Microbiota–Decanoic Acid–Interleukin-17A Axis Orchestrates Hyperglycemia-Induced Osteoporosis in Male Mice

This study investigated the role of gut microbiota dysbiosis in hyperglycemia-induced osteoporosis, a condition with unclear mechanisms. We explored whether gut microbiota dysbiosis drives bone loss in hyperglycemia and identified key microbial and molecular pathways. Hyperglycemic mice showed disturbed gut microbiota symbiosis, decreased Bifidobacterium pseudolongum, and elevated decanoic acid, which promoted T helper 17 differentiation and interleukin-17A (IL-17A) production, leading to osteoporosis. Fecal microbiota transplantation from control mice, B. pseudolongum supplementation, and IL-17A blockade alleviated bone loss, highlighting both B. pseudolongum supplementation and IL-17A inhibition as potential therapeutic strategies for hyperglycemia-induced osteoporosis.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-10-27
DOI
https://doi.org/10.2337/db25-0471
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gut Microbiota–Decanoic Acid–Interleukin-17A Axis Orchestrates Hyperglycemia-Induced Osteoporosis in Male Mice

Tao Jiang, Hongyan Zhao, Changkun Li, Bei Tao et al.
Diabetes
Bone Metabolism and Diseases
article

Gut Microbiota–Decanoic Acid–Interleukin-17A Axis Orchestrates Hyperglycemia-Induced Osteoporosis in Male Mice

Tao Jiang, Hongyan Zhao, Changkun Li, Bei Tao, Zhengying Pan, Xiaojing Chen, Lihao Sun, Jianmin Liu, Yanfang Hou, Yanyun Gu, Jiaxi Song, Yizhu Wang, Kecheng Zhu, Yuying Yang
article en

Abstract

This study investigated the role of gut microbiota dysbiosis in hyperglycemia-induced osteoporosis, a condition with unclear mechanisms. We explored whether gut microbiota dysbiosis drives bone loss in hyperglycemia and identified key microbial and molecular pathways. Hyperglycemic mice showed disturbed gut microbiota symbiosis, decreased Bifidobacterium pseudolongum, and elevated decanoic acid, which promoted T helper 17 differentiation and interleukin-17A (IL-17A) production, leading to osteoporosis. Fecal microbiota transplantation from control mice, B. pseudolongum supplementation, and IL-17A blockade alleviated bone loss, highlighting both B. pseudolongum supplementation and IL-17A inhibition as potential therapeutic strategies for hyperglycemia-induced osteoporosis.

DiabetesVol. 75(1)
Shanghai Jiao Tong University (CN), National Health and Family Planning Commission (CN), Ruijin Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN)
Openalex Percentile: Top 72%
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Gut Microbiota–Decanoic Acid–Interleukin-17A Axis Orchestrates Hyperglycemia-Induced Osteoporosis in Male Mice — Tao Jiang, Hongyan Zhao, et al. · Diabetes (2025) | TGRS Research Map | TGRS